Yordan Sbirkov
Overview
Explore the profile of Yordan Sbirkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vergov B, Sbirkov Y, Minchev D, Todorova T, Baldzhieva A, Burnusuzov H, et al.
Biol Methods Protoc
. 2024 Nov;
9(1):bpae042.
PMID: 39539388
Monitoring the blood serum activity of L-asparaginase in children with acute lymphoblastic leukaemia (ALL) has been highly recommended to detect enzyme inactivation that can cause relapse and to avoid unwanted...
2.
Sbirkov Y, Redzheb M, Forraz N, McGuckin C, Sarafian V
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540278
Technologies and biomaterials for 3D bioprinting have been developing extremely quickly in the past decade as they hold great potential in tissue engineering. This, together with the possibility to differentiate...
3.
Kazakova M, Ivanova T, Dikov D, Molander D, Simitchiev K, Sbirkov Y, et al.
Heliyon
. 2024 Mar;
10(5):e27570.
PMID: 38495157
Тhe poor prognosis of patients initially diagnosed at an advanced stage of colorectal cancer (CRC) and the heterogeneity within the same tumor stage define the need for additional predictive biomarkers....
4.
McGuckin C, Forraz N, Milet C, Lacroix M, Sbirkov Y, Sarafian V, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835418
Long-term modelization of cancer as it changes in the human body is a difficult goal, particularly when designing and testing new therapeutic strategies. This becomes even more difficult with metastasis...
5.
Gevezova M, Sbirkov Y, Sarafian V, Plaimas K, Suratanee A, Maes M
Brain Behav Immun Health
. 2023 Jun;
30:100646.
PMID: 37334258
Background: Despite advances in autism spectrum disorder (ASD) research and the vast genomic, transcriptomic, and proteomic data available, there are still controversies regarding the pathways and molecular signatures underlying the...
6.
Ivanova T, Mariienko Y, Mehterov N, Kazakova M, Sbirkov Y, Todorova K, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175443
At present it is well-defined that autophagy is a fundamental process essential for cell life but its pro-viral and anti-viral role has been stated out with the COVID pandemic. However,...
7.
Shopova D, Yaneva A, Bakova D, Mihaylova A, Kasnakova P, Hristozova M, et al.
Bioengineering (Basel)
. 2023 Mar;
10(3).
PMID: 36978678
The global development of technologies now enters areas related to human health, with a transition from conventional to personalized medicine that is based to a significant extent on (bio)printing. The...
8.
Sbirkov Y, Vergov B, Dzharov V, Schenk T, Petrie K, Sarafian V
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834787
The prognosis for patients with relapsed childhood acute lymphoblastic leukaemia (cALL) remains poor. The main reason for treatment failure is drug resistance, most commonly to glucocorticoids (GCs). The molecular differences...
9.
Molander D, Sbirkov Y, Sarafian V
Folia Med (Plovdiv)
. 2022 Aug;
64(4):559-565.
PMID: 36045467
Neoplastic diseases are a leading cause of death worldwide accounting for 10 million mortalities in 2020. Despite constantly revised and improved therapeutic regimens, the number of fatal cases increases annually....
10.
Sbirkov Y, Vergov B, Mehterov N, Sarafian V
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563051
Refractory disease and relapse remain the main causes of cancer therapy failure. Refined risk stratification, treatment regimens and improved early diagnosis and detection of minimal residual disease have increased cure...